GO	[-2.13 -0.32]	[-0.32 -0.22]	[-0.22 -0.15]	[-0.15 -0.09]	[-0.09 -0.04]	[-0.04 0.02]	[0.02 0.07]	[0.07 0.14]	[0.14 0.23]	[0.23 0.39]	[0.39 2.90]
QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORRELATED_WITH_CONTRACTION_OF_VZV_SPECIFIC_T_CELLS_PEAK_TO_28DYAT_1DY_NEGATIVE QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORRELATED_WITH_CONTRACTION_OF_VZV_SPECIFIC_T_CELLS_PEAK_TO_28DYAT_1DY_NEGATIVE	2.723	-0.528	2.169	-0.528	-0.528	0.319	-0.528	-0.932	0.556	-1.628	-0.523
HIPC_SIGNATURES_PROJECT_PBMC_TRIVALENT_INFLUENZA_VACCINE_HIGH_RESPONDERS_VS_LOW_RESPONDERS_YOUNGER_ADULTS_21_35_HIGH_RESPONDERS_0D_UP HIPC_SIGNATURES_PROJECT_PBMC_TRIVALENT_INFLUENZA_VACCINE_HIGH_RESPONDERS_VS_LOW_RESPONDERS_YOUNGER_ADULTS_21_35_HIGH_RESPONDERS_0D_UP	-0.207	-0.207	-0.207	3.509	-0.207	-0.207	-0.207	0.421	-0.207	-0.207	-0.206
